Sustained long-lasting responses after lenalidomide discontinuation in patients with chronic lymphocytic leukemia

被引：2
|
作者：
Strati, Paolo [1 ]
Ferrajoli, Alessandra [1 ]
Wierda, William G. [1 ]
Jain, Nitin [1 ]
Thompson, Philip A. [1 ]
O'Brien, Susan M. [1 ]
Rezvani, Katy [1 ]
Kantarjian, Hagop M. [1 ]
Burger, Jan A. [1 ]
Hinojosa, Christina O. [1 ]
Keating, Michael J. [1 ]
Estrov, Zeev [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
LEUKEMIA | 2018年 / 32卷 / 10期
关键词：
1ST-LINE THERAPY; CELLS; RITUXIMAB; CLL; CYCLOPHOSPHAMIDE; FLUDARABINE; OUTCOMES;
D O I：
10.1038/s41375-018-0059-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2278 / 2281
页数：4
相关论文
共 50 条
  • [31] QUICK PROGRESSION AFTER IBRUTINIB DISCONTINUATION IN PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Perez Gonzalez, J. A.
    Fernandez Jimenez, D.
    Sanchez Moreno, G.
    Gonzalez Navarro, P.
    Perez Gutierrez, E. M.
    Leyva Ferrer, R. N.
    HAEMATOLOGICA, 2019, 104 : 434 - 434
  • [32] Lenalidomide Alone and in Combination for Chronic Lymphocytic Leukemia
    Chen, Christine I.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2013, 8 (01) : 7 - 13
  • [33] LONG-LASTING VIABILITY OF HIV AFTER PATIENTS DEATH
    BALL, J
    DESSELBERGER, U
    WHITWELL, H
    LANCET, 1991, 338 (8758): : 63 - 63
  • [34] Lenalidomide as Initial Treatment of Elderly Patients with Chronic Lymphocytic Leukemia (CLL)
    Ferrajoli, Alessandra
    O'Brien, Susan
    Wierda, William
    Faderl, Stefan
    Kornblau, Steven
    Yerrow, Kimberly
    Estrov, Zeev
    Kantarjian, Hagop
    Keating, Michael
    BLOOD, 2008, 112 (11) : 23 - 23
  • [35] Long-lasting enhancement of CYP activity after discontinuation of repeated administration of phenobarbital in dogs
    Fukunaga, K.
    Saito, M.
    Matsuo, E.
    Muto, M.
    Mishima, K.
    Fujiwara, M.
    Orito, K.
    RESEARCH IN VETERINARY SCIENCE, 2009, 87 (03) : 455 - 457
  • [36] Long-lasting erythroid response after discontinuation of human recombinant erythropoietin in MDS patients: Report of three cases
    Niscola, P.
    Tendas, A.
    Giovannini, M.
    Scaramucci, L.
    Cupelli, L.
    Piccioni, D.
    Catalano, G.
    Perrotti, A.
    De Fabritiis, P.
    LEUKEMIA RESEARCH, 2013, 37 : S103 - S103
  • [37] A long-lasting, complete hematologic and cytogenetic remission of chronic myelogenous leukemia after treatment with busulfan alone
    Mandigers, CMPW
    Mensink, EJBM
    van Kessel, AG
    van der Plas, DC
    Haanen, C
    Hagemeÿer, A
    de Witte, T
    ANNALS OF HEMATOLOGY, 1996, 72 (06) : 371 - 373
  • [38] Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia
    Maddocks, Kami J.
    Ruppert, Amy S.
    Lozanski, Gerard
    Heerema, Nyla A.
    Zhao, Weiqiang
    Abruzzo, Lynne
    Lozanski, Arletta
    Davis, Melanie
    Gordon, Amber
    Smith, Lisa L.
    Mantel, Rose
    Jones, Jeffrey A.
    Flynn, Joseph M.
    Jaglowski, Samantha M.
    Andritsos, Leslie A.
    Awan, Farrukh
    Blum, Kristie A.
    Grever, Michael R.
    Johnson, Amy J.
    Byrd, John C.
    Woyach, Jennifer A.
    JAMA ONCOLOGY, 2015, 1 (01) : 80 - 87
  • [39] Multiple comorbidities in patients with long-lasting chronic spontaneous urticaria
    Agondi, Rosana Camara
    Argolo, Paula Natassya
    Mousinho-Fernandes, Mariana
    Gehlen, Bruna
    Kalil, Jorge
    Motta, Antonio Abilio
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2023, 98 (01) : 93 - 96
  • [40] Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation
    Khouri, Maria R.
    Jabbour, Elias J.
    Gulbis, Alison M.
    Turturro, Francesco
    Ledesma, Celina
    Korbling, Martin
    Samuels, Barry I.
    Ahmed, Sairah
    Alousi, Amin M.
    Ciurea, Stefan O.
    Marin, David
    Patel, Krina K.
    Popat, Uday R.
    Bueso-Ramos, Carlos E.
    Bassett, Roland L., Jr.
    Khouri, Issa F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (08) : 1405 - 1410
12345